DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
” Lina Khan - 2 “ - 1
Top related locs:
Top related orgs:
Federal Trade Commission - 2 Department of Health - 1 Human Services - 1

Search resuls for: "” Lina Khan"


2 mentions found


☆ U.S. Agencies Open Inquiry Into Generic Drug Shortages
  + stars: | 2024-02-14 | by ( Christina Jewett | ) www.nytimes.com   time to read: +1 min
The Federal Trade Commission and the Department of Health and Human Services said on Wednesday that they would examine the causes of generic drug shortages and the practices of “powerful middlemen” that are involved in the supply chain. The federal agencies’ inquiry is aimed at the group purchasing organizations and drug distributors that have been in the spotlight in recent months as drug shortages reached a 10-year peak. During Congressional hearings in the last year, oncology experts have testified about the effects of the shortages, describing difficult decisions that forced them to ration key chemotherapy drugs. “For years Americans have faced acute shortages of critical drugs, from chemotherapy to antibiotics, endangering patients,” Lina Khan, the F.T.C. “Our inquiry requests information on the factors driving these shortages and scrutinizes the practices of opaque drug middlemen.”
Persons: ” Lina Khan Organizations: Federal Trade Commission, Department of Health, Human Services
☆ Common Patenting Tactic by Drug Companies May Be Illegal, F.T.C. Says
  + stars: | 2023-09-14 | by ( Rebecca Robbins | More About Rebecca Robbins | ) www.nytimes.com   time to read: +1 min
The Federal Trade Commission on Thursday issued what amounted to a warning to pharmaceutical companies about the legality of a widespread patenting strategy that experts say has helped keep inhaler costs high for patients with asthma and lung problems. In a policy statement unanimously endorsed by the agency’s commissioners, the F.T.C. said it “intends to scrutinize” whether companies are illegally engaging in an unfair method of competition when they exploit a regulatory loophole that can delay rivals from entering the market. The policy statement did not single out any particular products. “This seems to be a real problem, and one that could really be contributing to unaffordable medicines and drug products,” Lina Khan, the F.T.C.
Persons: “, ” Lina Khan Organizations: Federal Trade Commission
0 next >>
Total: 2